A quick peek into the report
Table of Contents
1.1 Trends: Current and Future Impact Assessment
1.1.1 Increasing Strategic Partnerships and Alliances between Market Players
1.1.2 Expanding Applications in NIPT Products
1.2 Supply Chain Overview
1.3 Research and Development Review
1.3.1 Patent Filing Trend (by Country, Year)
1.4 Regulatory Landscape
1.4.1 Regulatory Scenario in China
1.4.2 Regulatory Scenario in India
1.4.3 Regulatory Scenario in Australia
1.4.4 Regulatory Scenario in Japan
1.5 Reimbursement Scenario
1.6 Market Dynamics Overview
1.6.1 Market Drivers
1.6.1.1 High Incidence of Genetic Disorders
1.6.1.2 Rising Maternal Age
1.6.1.3 Increasing Number of Reimbursement Policies toward Genetic Coverage
1.6.1.4 Increased Emphasis on Early Detection and Prevention
1.6.2 Market Restraints
1.6.2.1 Stringent Regulatory Guidelines and Ethical Hurdles
1.6.2.2 Lack of Awareness Regarding NIPT
1.6.2.3 Limitations and Considerations in Non-Invasive Prenatal Testing
1.6.3 Market Opportunities
1.6.3.1 Leveraging the Opportunities Arising from the Growing Markets in Asia
1.6.3.2 Increasing Focus on Non-Invasive Pre-Implantation Genetic Testing (niPGT)
2.1 Drivers and Restraints
2.2 Regional Summary
2.3 Asia-Pacific
2.3.1 Regional Overview
2.3.2 Driving Factors for Market Growth
2.3.3 Factors Challenging the Market
2.3.4 Application
2.3.5 Product
2.3.6 China
2.3.7 India
2.3.8 Japan
2.3.9 Rest-of-Asia-Pacific
3.1 Competitive Landscape
3.1.1 BGI Genomics
3.1.1.1 Overview
3.1.1.2 Product Portfolio
3.1.1.3 Top Competitors
3.1.1.4 Target Customers
3.1.1.5 Key Personnel
3.1.1.6 Analyst View
3.1.2 Annoroad Gene Technology
3.1.2.1 Overview
3.1.2.2 Product Portfolio
3.1.2.3 Top Competitors
3.1.2.4 Target Customers
3.1.2.5 Key Personnel
3.1.2.6 Analyst View
4.1 Data Sources
4.1.1 Primary Data Sources
4.1.2 Secondary Data Sources
4.1.3 Data Triangulation
4.2 Market Estimation and Forecast
Table 1: Market Snapshot
Table 2: Non-Invasive Prenatal Testing Market, Opportunities
Table 3: Key Companies’ Partnerships and Alliances
Table 4: NIPT Tests in the NIPT Market and their Corresponding Applications
Table 5: Risk of Chromosomal Abnormality w.r.t Maternal Age
Table 6: Non-Invasive Prenatal Testing Market (by Region), Thousands Units, 2022-2033
Table 7: Non-Invasive Prenatal Testing Market (by Region), $Million, 2022-2033
Table 8: Asia-Pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 9: Asia-Pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 10: Asia-Pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 11: Asia-Pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 12: China Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 13: China Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 14: China Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 15: China Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 16: India Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 17: India Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 18: India Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 19: India Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 20: Japan Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 21: Japan Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 22: Japan Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 23: Japan Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 24: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 25: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 26: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 27: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 28: Market Share (2022)
Figure 1: Asia-pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022, 2026, and 2033
Figure 2: Asia-pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022, 2026, and 2033
Figure 3: Asia-pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022, 2026, and 2033
Figure 4: Asia-pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022, 2026, and 2033
Figure 5: Non-Invasive Prenatal Testing Market, Recent Developments, 2023
Figure 6: Supply Chain of NIPT Market
Figure 7: NIPT Market, Patent Analysis, (by Country), January 2020-December 2023
Figure 8: NIPT Market, Patent Analysis, (by Year), January 2020-December 2023
Figure 9: Reimbursement Scenario in Major Countries of the NIPT Market
Figure 10: Impact Analysis of Market Navigating Factors, 2022-2033
Figure 11: Age of Mother at Childbirth over the Years
Figure 12: Reimbursement Scenario in Major Countries
Figure 13: Number of Tests Processed by Natera, Inc., 2018-2020
Figure 14: Positives from Data of 75,000 NIPT Tests Showing False Positives
Figure 15: Recent Developments in APAC by Key Companies
Figure 16: Asia-Pacific Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 17: Asia-Pacific Non-Invasive Prenatal Testing Market, $Million, 2023-2033
Figure 18: China Non-Invasive Prenatal Testing Market, Thousand, 2023-2033
Figure 19: China Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 20: India Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 21: India Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 22: Japan Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
Figure 23: Japan Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 24: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
Figure 25: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 26: Share of Strategic Initiatives
Figure 27: Data Triangulation
Figure 28: Top-Down and Bottom-Up
Figure 29: Assumptions and Limitations
Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market Report Coverage
|
Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market |
|||
|
Base Year |
2022 |
Market Size in 2023 |
$659.2 Million |
|
Forecast Period |
2023-2033 |
Value Projection and Estimation by 2033 |
$2,767.3 Million |
|
CAGR During Forecast Period |
15.43% |
|
|
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.
Some prominent names established in this market are:
• BGI Genomics
• Annoroad Gene Technology
How can this report add value to an organization?
Workflow/Innovation Strategy: The Asia-Pacific NIPT market (by application) has been segmented into detailed segments of the application of NIPT based on applications, including trisomy detection, microdeletion detection, sex chromosome aneuploidy detection, and others.
Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enabled prominent players to command premium prices while maintaining growth in revenue and volume.
Competitive Strategy: Key players in the Asia-Pacific NIPT market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific NIPT market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Introduction to Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market
The Asia-Pacific NIPT market was valued at $659.2 million in 2023 and is expected to reach $2,767.3 million by 2033, registering a CAGR of 15.43% during the forecast period 2023-2033. The adoption of supportive healthcare policies, the growing inclusion of screening procedures in insurance coverage, ongoing technological advancements, the expansion of commercial opportunities throughout the region, and the growing preference for non-invasive testing methods among expectant parents and healthcare providers are the main factors propelling the APAC NIPT market.
Market Introduction
The market for non-invasive prenatal testing (NIPT) in Asia-Pacific is expanding significantly due to increased healthcare spending in the region and growing knowledge of sophisticated prenatal screening techniques. Because of its great accuracy, safety, and non-invasiveness, NIPT—a ground-breaking technology that examines cell-free fetal DNA from maternal blood—is becoming more and more popular. During pregnancy, it is frequently used to identify chromosomal abnormalities such Patau syndrome, Edwards syndrome, and Down syndrome.
Growing maternal age, the use of sophisticated genetic technologies, and the need for accurate and timely prenatal diagnostics are driving the market's growth. The adoption of NIPT is being further supported by the expansion of insurance coverage for prenatal care and the implementation of healthcare reforms in many Asia-Pacific nations.
The market's major players are concentrating on creating affordable testing solutions to serve the region's diverse population and range of income levels. Partnerships between international corporations and regional healthcare providers are increasing awareness and accessibility, especially in developing nations.
As prenatal health awareness rises and healthcare infrastructure improves, the APAC NIPT market is expected to grow rapidly. It will be crucial in improving maternal and fetal health outcomes throughout the area.
Market Segmentation:
Segmentation 1: by Application
• Trisomy Detection
• Microdeletion Detection
• Sex Chromosome Aneuploidy Detection
• Others
Segmentation 2: by End User
• Hospitals
• Diagnostic Laboratories
• Others
Segmentation 3: by Platform
• NGS
• PCR
• Others
Segmentation 4: by Method
• cfDNA
• FCMB
Segmentation 5: by Country
• China
• India
• Japan
• Rest-of-Asia-Pacific
Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market
Focus on Method, Platform, End User, Application, and Country - Analysis and Forecast, 2023-2033
Frequently Asked Questions
Manufacturers, CROs, CMOs, and CDMOs focusing on healthcare products can buy this report.
The global NIPT market was valued at $3,350.4 million in 2023 and is expected to reach $12,870.9 million by 2033, registering a CAGR of 14.41% during the forecast period 2023-2033.
- · Market Growth Potential
- · Patent Analysis
- · Regulatory Framework
- · Market Dynamics
- · Market Opportunities
- · Detailed Segmentation such as Application, End User, and Product
- · Region and Country-Level Market Size and Forecast for Application, End User, Test, Method, and Platform
- · Competitive Landscape
Key trends in the APAC NIPT market include increasing adoption of advanced genomic technologies, growing awareness of non-invasive prenatal testing, rising healthcare investments, expanding insurance coverage for prenatal screening, and the development of cost-effective NIPT solutions. The region also sees increasing collaboration between global players and local healthcare providers.